Ben Arye Barak bought NVCR
February 27, 2024 · Form 4 insider transaction
Ben Arye Barak bought 125,078 shares of NovoCure Limited at $16.30 per share, a transaction worth $2.04M. The trade was recorded as grant or award and disclosed on an SEC Form 4, filed 2 days after the transaction.
Direction
Acquired (buy-side)
Shares
125,078
Price
$16.30
Total value
$2.04M
InsiderBen Arye Barak
RoleOfficer
CompanyNovoCure Limited (NVCR)
SecurityStock Options (Right to buy)
Transaction codeA: Grant or award
Transaction dateFebruary 27, 2024
Filing dateFebruary 29, 2024
Shares owned after125,078
OwnershipDirect
10b5-1 planNo
AmendedNo
Footnotes
Options to buy 125,078 ordinary shares will vest in equal installments on each of February 27, 2025, 2026, 2027 and 2028, subject to the reporting person's continued employment through such dates.